Media Summary: HER2+ early breast cancer has been revolutionized by the development of This study is looking to decrease the amount of chemotherapy used for people with Dr. Yifan Tu, from Southeast Health, shares her experience with toxicity management using dose escalation and incorporating ...
Optimizing Therapy In Her2 Disease - Detailed Analysis & Overview
HER2+ early breast cancer has been revolutionized by the development of This study is looking to decrease the amount of chemotherapy used for people with Dr. Yifan Tu, from Southeast Health, shares her experience with toxicity management using dose escalation and incorporating ... Dr. Sayeh Lavasani, from City of Hope National Cancer Institute, shares her experience with toxicity management using dose ... Although there has been considerable progress in the Sung-Bae Kim, MD, PhD, Asan Medical Center, Seoul, Korea, discusses
Virginia Kaklamani, MD, UT Health San Antonio, San Antonio, TX, discusses the various Dr. Francis Arena, from NYU Langone Health, shares his experience with toxicity management using dose escalation.
